Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

Cell

Volumn 80, Issue 2, 1995, Pages 293-299

  Toshiyuki, Miyashita ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BINDING SITE; CANCER CELL; CELL DEATH; GENE ACTIVATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REPORTER GENE;

BASE SEQUENCE; BINDING SITES; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; COMPARATIVE STUDY; CONSENSUS SEQUENCE; COSMIDS; FEMALE; GENE EXPRESSION; GENE LIBRARY; HUMAN; MOLECULAR SEQUENCE DATA; MUTAGENESIS; OLIGODEOXYRIBONUCLEOTIDES; PLACENTA; PLASMIDS; PREGNANCY; PROMOTER REGIONS (GENETICS); PROTEIN P53; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; RESTRICTION MAPPING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 0028883179     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(95)90412-3     Document Type: Article

References (48)

1. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis
2. Mad: a heterodimeric partner for Max that antagonizes Myc transcription activity
3. Apoptotic cell death induced by c-myc is inhibited by bcl-2
4. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc
5. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras
6. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes
7. Thymocyte apoptosis induced by p53-dependent and independent pathways
8. Definition of a consensus binding site for p53
9. WAF1, a potential mediator of p53 tumor suppression
10. Induction of apoptosis in fibroblasts by c-myc protein
11. Apoptosis in cancer therapy: crossing the threshold
12. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal
13. The p21 CDK-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases
14. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
15. p53 mutations in human cancers
16. Regulation of the specific DNA binding function of p53
17. Oncogenic forms of p53 inhibit p53-regulated gene expression
18. Investigations of antisense oligonucleotides targeted against bcl-2 RNAs
19. Reversal of chemoresistance of lymphoma cells by antisensemediated reduction of bcl-2 gene expression
20. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2
21. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
22. p53 is required for radiation-induced apoptosis in mouse thymocytes
23. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?
24. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53
25. Tumor suppressor p53 is a regulator of bcl-2 and bax in gene expression in vitro and in vivo
26. Identification of a p53-dependent negative response element in the bcl-2 gene
27. Disappearance of the lymphoid system in bcl-2 homozygous mutant chimeric mice
28. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
29. The helix-loop-helix/leucine repeat transcription factor USF can be functionally regulated in a redox-dependent manner
30. Bcl-2 and the regulation of programmed cell death
31. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle
32. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system
33. Mammalian p53 can function as a transcription factor in yeast
34. Immediate early up-regulation of bax expression by p53 but not TGFβ1: a paradigm for distinct apoptotic pathways
35. Induction of apoptosis by wild-type p53 in a human colon tumorderived cell line
36. Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region
37. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
38. p53-dependent apoptosis suppresses tumor growth and progression in vivo
39. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers
40. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
41. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation
42. p53 function and dysfunction
43. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line
44. p53 and E2F-1 cooperate to mediate apoptosis
45. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
46. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
47. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites
48. Induction of cellular p53 activity by DNA-damaging agents and growth arrest